Dr. Brad Jones, Division of Infectious Diseases, began a collaboration several years ago involving T-cell therapy approaches to HIV that has played a key role in a breakthrough study on COVID-19.
These awards are supported by a grant from the Health Resources and Services Administration (HRSA) to the Weill Cornell Medicine Diversity Center of Excellence of the Cornell Center for Health Equity.
Investigators at Weill Cornell Medicine and NewYork-Presbyterian are recruiting 1,000 asymptomatic health care workers for a study on COVID-19 that seeks to answer the question: why do some people become severely ill, while others have no symptoms?
The WDOM congratulates three of its faculty - Drs. Julie Magarian Blander, Robert Peck, and Erica Phillips - who received grants from Weill Cornell Medicine in support of their innovative research on COVID-19.
Until now, vital data had been lacking on graft and patient outcomes in kidney transplant recipients and the management of their immunosuppression in the setting of Covid-19.
The paper shares observations from the COVID-19 epidemic, while highlighting patient care inequities seen in socioeconomically disadvantaged communities.
Until a vaccine is discovered and implemented for COVID-19, WDOM physicians on the frontlines continue to focus on diagnosis, drug treatment options, and best practices.
As of June 1, 2020, more than $80,000 was raised from 180 donors – more than 160% of our initial $50,000 goal – to support the academic efforts of our trainees and junior faculty.
#HairstylesForHeroes is a fundraising initiative to support Weill Cornell Medicine’s Department of Medicine junior faculty members and trainees, who have served on the front lines of the pandemic response.
The guidelines will draw on the knowledge of a panel of experts and will be updated frequently with scientific evidence and data to inform clinicians on how to best manage patients with COVID-19.
